Company: AEMD
Filing Date: 2025-06-26
Form Type: 10-K
Source: 0001683168-25-004780
Chunk: 626

Company: AETHLON MEDICAL INC
Filing Date: 2025-06-26
Form: 10-K
Item: Item 2
Chunk 626
---
55  
     4,090  
    $20.09 
  
    Exercisable, end of year 
     2,357,124  
    $3.55  
     4,090  
    $20.09 
  
    Weighted average estimated fair value of warrants granted 
        
    $N/A  
        
    $N/A 

The detail of the warrants outstanding and exercisable as of March
31, 2025 is as follows:

    Schedule of warrant activity exercisable and outstanding 

     Warrants Outstanding  
     Warrants Exercisable 
  
    Range of  Exercise Prices 
     Number  Outstanding  
     Weighted Average  Remaining  Life (Years)  
     Weighted  Average  Exercise Price  
     Number  Outstanding  
     Weighted  Average  Exercise Price 
  
    $4.64 or Below 
     2,357,124  
     4.63  
    $3.55  
     2,357,124  
    $3.55 

The detail of the warrants outstanding and exercisable as of March
31, 2024 is as follows:

    Warrants Outstanding  
    Warrants Exercisable 
  
    Range of  Exercise Prices 
    Number  Outstanding  
    Weighted Average  Remaining  Life (Years)  
    Weighted  Average  Exercise Price  
    Number  Outstanding  
    Weighted  Average  Exercise Price 
  
    $150.00 or Below 
     2,531  
     0.71  
    $125.28  
     2,531  
    $125.28 
  
    $200.00 - $220.00 
     1,559  
     0.81  
    $218.24  
     1,559  
    $218.24 

     4,090  

     4,090  

     F-19 

STOCK-BASED COMPENSATION:

2020 EQUITY INCENTIVE PLAN

The
2020 Equity Incentive Plan (the “2020 Plan”) was approved by our stockholders in September 2020 to provide stock-based incentives
to attract, retain, and motivate employees, directors, and consultants. The plan initially authorized 21,023 shares of